Allergy and Immunology · Chelmsford, MA
NPI
1760400634
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9 Village Sq
Chelmsford, MA, 01824
Phone (978) 256-4531
Groups this clinician bills Medicare through
Medicare paid, 2024
$50K
2,104 services
Medicare patients, 2024
211
Average age 73
Drug cost, 2024
$1.8M
757 prescriptions
Company payments, 2025
$1,586
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ami Mehra was code 95004 (test - miscellaneous), 855 times for 19 patients. In total Ami Mehra billed 2,104 services in 25 codes, and Medicare paid $50K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 855 | 19 | $2.84 | $2,430 |
| 99214 Office E&M - Established | Office | 224 | 118 | $100.06 | $22K |
| 96372 Injection Administration | Office | 218 | 63 | $11.79 | $2,571 |
| 95117 Treatment - Miscellaneous | Office | 189 | 62 | $8.95 | $1,692 |
| 95024 Test - Miscellaneous | Office | 162 | 14 | $6.78 | $1,098 |
| 95018 Test - Miscellaneous | Office | 136 | 12 | $18.04 | $2,454 |
| 99213 Office E&M - Established | Office | 101 | 49 | $72.78 | $7,351 |
| 95115 Treatment - Miscellaneous | Office | 43 | 17 | $7.95 | $342 |
| 94010 Pulmonary Function Testing | Office | 35 | 32 | $20.46 | $716 |
| 99215 Office E&M - Established | Office | 23 | 15 | $126.63 | $2,913 |
| G0008 Administration of influenza virus vaccine | Office | 14 | 14 | $33.57 | $470 |
| 99204 Office E&M - New | Office | 13 | 13 | $129.64 | $1,685 |
By year: 2022 $65K for 2,633 services; 2023 $65K for 2,232 services; 2024 $50K for 2,104 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ami Mehra prescribed most often to Medicare patients was Montelukast Sodium, with 95 prescriptions and refills. In total Ami Mehra wrote 757 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 95 | 227 | 32 | $1,507 |
| Breo Ellipta Fluticasone/Vilanterol | 81 | 141 | 20 | $53K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 60 | 78 | 15 | $48K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 44 | 53 | 29 | $1,188 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 41 | 82 | 11 | $8,104 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 36 | 36 | Under 11 | $99K |
| Fluticasone Propionate Generic | 32 | 54 | Under 11 | $554 |
| Prednisone Generic | 26 | 26 | 21 | $102 |
| Arnuity Ellipta Fluticasone Furoate | 23 | 39 | Under 11 | $8,595 |
| Epinephrine Generic | 23 | 23 | 21 | $3,596 |
| Azelastine Hcl Generic | 16 | 30 | Under 11 | $561 |
| Xolair Omalizumab | 15 | 15 | Under 11 | $38K |
| Advair Hfa Fluticasone Propion/Salmeterol | 15 | 41 | Under 11 | $14K |
| Orladeyo Berotralstat Hydrochloride | 14 | 14 | Under 11 | $577K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 13 | 21 | Under 11 | $13K |
Brand drugs: 383 claims; generic drugs: 374 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ami Mehra $1,586 ($1,586 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $203.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 5 | $203 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $189 |
| Pfizer Inc. PFE | 9 | $177 |
| BioCryst US Sales Co., LLC | 7 | $158 |
| CSL Behring CSL.AX | 7 | $150 |
| GlaxoSmithKline, LLC. GSK | 8 | $137 |
| Amgen Inc. AMGN | 3 | $95.13 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $86.73 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $85.2 |
| Lilly USA, LLC LLY | 3 | $76.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.